£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

HIV and AIDS Therapeutics Outlook 2023-2028 - US Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days · 18 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 03 August 2026 07 August 2026 11 August 2026 15 August 2026 20 August 2026
View at Amazon ↗

Price data last checked 73 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 18 days • 1 price levels

Days at Price
18 days 0 5 9 14 18 £520 Days at Price

Price Analysis

Most common price: £520 (18 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 18 days

Description

This comprehensive study provides a detailed outlook for HIV and AIDS therapeutics in the United States from 2023 to 2028. It focuses on latent demand, providing potential industry earnings (P.I.E.) estimates in millions of U.S. dollars. The data covers approximately 12,600 cities across the country, offering a granular view of the market. By reporting the percent share each city holds relative to its state and the United States as a whole, these comparative benchmarks help users gauge specific locations against others. This statistical approach is designed to assist with sales force strategies and distribution planning through the use of econometric modeling.

Key Features

Provides latent demand outlook for HIV and AIDS therapeutics across United States states and cities from 2023 to 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for approximately 12,600 cities.

Offers comparative benchmarks by reporting the percent share of each city relative to its state and the entire United States.

Supports distribution and sales force strategies through detailed statistical data and econometric modeling.

Published by ICON Group International, Inc. to provide specific market insights for the pharmaceutical industry.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for HIV and AIDS Therapeutics in India
99% match

The 2023-2028 Outlook for HIV and AIDS Therapeutics in India

£515.00 21 Aug 2026
HIV-AIDS Testing Outlook 2023-2028 - US Market Study
99% match

HIV-AIDS Testing Outlook 2023-2028 - US Market Study

£520.00 20 Aug 2026
The 2023-2028 Outlook for HIV and AIDS Therapeutics in China
99% match

The 2023-2028 Outlook for HIV and AIDS Therapeutics in China

£495.00 12 Sep 2026
The 2016-2021 Outlook for Human Immunodeficiency Virus (HIV) Treatments in the United States
99% match

The 2016-2021 Outlook for Human Immunodeficiency Virus (HIV) Treatments in the United States

£595.00 22 Aug 2026
The 2016-2021 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Greater China
99% match

The 2016-2021 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Greater China

£595.00 04 Sep 2026
The 2009-2014 World Outlook for Human Immunodeficiency Virus (HIV) Treatments
99% match

The 2009-2014 World Outlook for Human Immunodeficiency Virus (HIV) Treatments

£795.00 11 Sep 2026
The 2016-2021 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Japan
98% match

The 2016-2021 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Japan

£595.00 28 Oct 2026
The 2021-2026 World Outlook for Human Immunodeficiency Virus (HIV) Treatments
98% match

The 2021-2026 World Outlook for Human Immunodeficiency Virus (HIV) Treatments

£795.00 26 Aug 2026
The 2016-2021 Outlook for HIV/AIDS Monitoring Test in the United States
98% match

The 2016-2021 Outlook for HIV/AIDS Monitoring Test in the United States

£595.00 26 Aug 2026
The 2023-2028 Outlook for Blood Test in HIV Self-Testing in the United States
98% match

The 2023-2028 Outlook for Blood Test in HIV Self-Testing in the United States

£520.00 20 Aug 2026
The 2023-2028 Outlook for Blood Test in HIV Self-Testing in India
98% match

The 2023-2028 Outlook for Blood Test in HIV Self-Testing in India

£515.00 24 Sep 2026
The 2023-2028 World Outlook for HIV-AIDS Confirmatory Tests
98% match

The 2023-2028 World Outlook for HIV-AIDS Confirmatory Tests

Price unavailable
The 2016 Report on Human Immunodeficiency Virus (HIV) Treatments: World Market Segmentation by City
98% match

The 2016 Report on Human Immunodeficiency Virus (HIV) Treatments: World Market Segmentation by City

£995.00 04 Sep 2026
The 2016-2021 Outlook for HIV/AIDS Confirmatory Tests in Greater China
98% match

The 2016-2021 Outlook for HIV/AIDS Confirmatory Tests in Greater China

£595.00 26 Aug 2026
The 2026-2031 World Outlook for HIV and AIDS Testing
98% match

The 2026-2031 World Outlook for HIV and AIDS Testing

£885.00 26 Sep 2026
The 2021-2026 World Outlook for HIV/AIDS Testing
98% match

The 2021-2026 World Outlook for HIV/AIDS Testing

£795.00 24 Sep 2026
The 2027-2032 World Outlook for HIV and AIDS Testing
98% match

The 2027-2032 World Outlook for HIV and AIDS Testing

£890.00 26 Sep 2026
The 2013-2018 Outlook for Human Immunodeficiency Virus (HIV) Treatments in India
98% match

The 2013-2018 Outlook for Human Immunodeficiency Virus (HIV) Treatments in India

£495.00 20 Aug 2026
HIV Treatment Outlook 2013-2018 - North America & Caribbean
98% match

HIV Treatment Outlook 2013-2018 - North America & Caribbean

£325.00 21 Aug 2026
98% match

The 2009-2014 Outlook for Human Immunodeficiency Virus (HIV) Treatments in The Middle East & Africa

£325.00 26 Aug 2026
HIV Treatment Outlook in Latin America (2013-2018) Report
98% match

HIV Treatment Outlook in Latin America (2013-2018) Report

£325.00 22 Aug 2026
The 2013-2018 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Asia
98% match

The 2013-2018 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Asia

£325.00 22 Aug 2026
The 2011-2016 Outlook for Human Immunodeficiency Virus (HIV) Treatments in The Americas & the Caribbean
98% match

The 2011-2016 Outlook for Human Immunodeficiency Virus (HIV) Treatments in The Americas & the Caribbean

£325.00 03 Sep 2026
HIV/AIDS Monitoring Test Outlook: Africa & Middle East
98% match

HIV/AIDS Monitoring Test Outlook: Africa & Middle East

£325.00 03 Sep 2026